EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

A Goette, JM Kalman, L Aguinaga, J Akar… - Heart …, 2016 - pmc.ncbi.nlm.nih.gov
The atria provide an important contribution to cardiac function. 1, 2 Besides their impact on
ventricular filling, they serve as a volume reservoir, host pacemaker cells and important parts …

Atrial fibrillation and stroke

SE Choi, D Sagris, A Hill, GYH Lip… - Expert Review of …, 2023 - Taylor & Francis
Introduction Stroke is one of the leading causes of mortality and morbidity globally. Atrial
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

A Goette, JM Kalman, L Aguinaga, J Akar… - Ep …, 2016 - academic.oup.com
The atria provide an important contribution to cardiac function. 1, 2 Besides their impact on
ventricular filling, they serve as a volume reservoir, host pacemaker cells and important parts …

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Z Hijazi, J Oldgren, J Lindbäck, JH Alexander… - The Lancet, 2016 - thelancet.com
Background The benefit of oral anticoagulation in atrial fibrillation is based on a balance
between reduction in ischaemic stroke and increase in major bleeding. We aimed to …

Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate

JJ Goldberger, R Arora, D Green, P Greenland… - Circulation, 2015 - Am Heart Assoc
Atrial disease or myopathy forms the substrate for atrial fibrillation (AF) and underlies the
potential for atrial thrombus formation and subsequent stroke. Current diagnostic …

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

M Kimachi, TA Furukawa, K Kimachi… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic kidney disease (CKD) is an independent risk factor for atrial fibrillation
(AF), which is more prevalent among CKD patients than the general population. AF causes …

Novel risk markers and risk assessments for cardiovascular disease

MR Thomas, GYH Lip - Circulation research, 2017 - Am Heart Assoc
The use of risk markers has transformed cardiovascular medicine, exemplified by the routine
assessment of troponin, for both diagnosis and assessment of prognosis in patients with …

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Z Hijazi, J Oldgren, J Lindbäck… - European heart …, 2018 - academic.oup.com
Aims In atrial fibrillation (AF), mortality remains high despite effective anticoagulation. A
model predicting the risk of death in these patients is currently not available. We developed …

The prothrombotic state in atrial fibrillation: pathophysiological and management implications

AA Khan, GYH Lip - Cardiovascular research, 2019 - academic.oup.com
Atrial fibrillation (AF) is the commonest sustained cardiac arrhythmia and is associated with
significant morbidity and mortality. There is plenty of evidence available to support the …

Application of biomarkers for risk stratification in patients with atrial fibrillation

Z Hijazi, J Oldgren, A Siegbahn, L Wallentin - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Atrial fibrillation is the most common sustained arrhythmia and an important
contributor to cardiovascular morbidity and mortality. Several strategies have been proposed …